フォロー
Smita Kumari, PhD
タイトル
引用先
引用先
Combinatorial therapy in tumor microenvironment: where do we stand?
S Kumari, D Advani, S Sharma, RK Ambasta, P Kumar
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1876 (2), 188585, 2021
882021
New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson’s disease
R Gupta, S Kumari, A Senapati, RK Ambasta, P Kumar
Ageing research reviews 90, 102013, 2023
762023
Unboxing the molecular modalities of mutagens in cancer
S Kumari, S Sharma, D Advani, A Khosla, P Kumar, RK Ambasta
Environmental Science and Pollution Research, 1-49, 2021
582021
Computationally designed antibody–drug conjugates self-assembled via affinity ligands
N Gupta, A Ansari, GV Dhoke, M Chilamari, J Sivaccumar, S Kumari, ...
Nature biomedical engineering 3 (11), 917-929, 2019
292019
Multiple therapeutic approaches of glioblastoma multiforme: from terminal to therapy
S Kumari, R Gupta, RK Ambasta, P Kumar
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1878 (4), 188913, 2023
262023
Precision oncology, signaling, and anticancer agents in cancer therapeutics
D Advani, S Sharma, S Kumari, RK Ambasta, P Kumar
Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents) 22 (3), 433-468, 2022
232022
Activation of epithelial-mesenchymal transition and altered β-catenin signaling in a novel Indian colorectal carcinoma cell line
S Mylavarapu, H Kumar, S Kumari, LS Sravanthi, M Jain, A Basu, ...
Frontiers in Oncology 9, 54, 2019
172019
Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseases
R Gupta, S Kumari, R Tripathi, RK Ambasta, P Kumar
Ageing Research Reviews 86, 101855, 2023
122023
A safe and efficacious Pt (ii) anticancer prodrug: design, synthesis, in vitro efficacy, the role of carrier ligands and in vivo tumour growth inhibition
PK Dutta, R Sharma, S Kumari, RD Dubey, S Sarkar, J Paulraj, ...
Chemical Communications 55 (12), 1718-1721, 2019
112019
Design and computational analysis of an mmp9 inhibitor in hypoxia-induced glioblastoma multiforme
S Kumari, P Kumar
ACS omega 8 (11), 10565-10590, 2023
102023
Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme
S Kumari, R Gupta, RK Ambasta, P Kumar
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1878 (6), 188999, 2023
62023
Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment
S Kumari, P Kumar
Frontiers in Cell and Developmental Biology 11, 2023
42023
IO-125: A novel supramolecular platinum chemotherapy for triple negative breast cancer.
A Sengupta, S Mylavarapu, S Kumari, S Hossain, N Gupta, A Sarkar, ...
Journal of Clinical Oncology 33 (28_suppl), 153-153, 2015
22015
Phenalenyl based platinum anticancer compounds with superior efficacy: design, synthesis, characterization, and interaction with nuclear DNA
P Dutta, S Kumari, J Paulraj, R Sharma, G Vijaykumar, HS Das, ...
New Journal of Chemistry 45 (23), 10524-10533, 2021
12021
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–14